Hepatocyte growth factor (HGF): Neurotrophic functions and therapeutic implications for neuronal injury/diseases

Current Signal Transduction Therapy

Volumn 6, Issue 2, 2011, Pages 156-167

  Funakoshi, Hiroshi ^a,c   Nakamura, Toshikazu ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); Autophagy; c Met; HGF; Neurotrophic; Spinal cord injury (SCI)

Indexed keywords

RECOMBINANT SCATTER FACTOR; RILUZOLE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY DISORDER; ARTICLE; AUTISM; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CONTINUOUS INFUSION; DEGENERATIVE DISEASE; DRUG MECHANISM; GENE DELIVERY SYSTEM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEARING IMPAIRMENT; HEARING LOSS; HYDROCEPHALUS; IN VITRO STUDY; LEARNING DISORDER; MEMORY DISORDER; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INJURY; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NEUROTROPISM; NONHUMAN; PARKINSON DISEASE; PERIPHERAL NERVE INJURY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA INJURY; SCHIZOPHRENIA; SEIZURE; SPINAL CORD INJURY;

EID: 79957968386     PISSN: 15743624     EISSN: 15743624     Source Type: Journal    
DOI: 10.2174/157436211795659982     Document Type: Article

References (124)

1. Colangelo AM, Finotti N, Ceriani M, et al. Recombinant human nerve growth factor with a marked activity in vitro and in vivo. Proc Natl Acad Sci USA 2005; 102: 18658-63. (Pubitemid 43011282)
2. Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci (Lond) 2006; 110: 167-73. (Pubitemid 43241478)
3. Funakoshi H, Belluardo N, Arenas E, et al. Muscle-derived neurotrophin- 4 as an activity-dependent trophic signal for adult motor neurons. Science 1995; 268: 1495-9.
4. Funakoshi H, Risling M, Carlstedt T, et al. Targeted expression of a multifunctional chimeric neurotrophin in the lesioned sciatic nerve accelerates regeneration of sensory and motor axons. Proc Natl Acad Sci USA 1998; 95: 5269-74. (Pubitemid 28208587)
5. Trupp M, Ryden M, Jornvall H, et al. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol 1995; 130: 137-48.
6. Muller-Newen G.. The cytokine receptor gp130: faithfully promiscuous. Sci STKE 2003; 2003: PE40.
7. Emerich DF, Thanos CG.. NT-501: an ophthalmic implant of polymer-encapsulated ciliary neurotrophic factor-producing cells. Curr Opin Mol Ther 2008; 10: 506-15.
8. Funakoshi H, Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 2003; 327: 1-23. (Pubitemid 35447813)
9. Nakamura T. Hepatocyte growth factor and Met receptor, from discovery and the therapeutic implications. Current Signal Transduction Therapy 2011: in press.
10. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jap Acad Ser-B 2010; 86: 588-610.
11. Maina F, Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci 1999; 2: 213-217. (Pubitemid 30491290)
12. Ohya W, Funakoshi H, Kurosawa T, Nakamura T. Hepatocyte growth factor (HGF) promotes oligodendrocyte progenitor cell proliferation and inhibits its differentiation during postnatal development in the rat. Brain Res 2007; 1147: 51-65. (Pubitemid 46574566)
13. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996; 119: 591-600. (Pubitemid 26131762)
14. Kadoyama K, Kadoyama K, Funakoshi H, Nakamura T, Sakaeda T. Therapeutic Potential of Hepatocyte Growth Factor for Treating Neurological Diseases. Current Drug Therapy 2011: in press.
15. Jung W, Castren E, Odenthal M, et al. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol 1994; 126: 485-94. (Pubitemid 24226264)
16. Honda S, Kagoshima M, Wanaka A, Tohyama M, Matsumoto K, Nakamura T. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res Mol Brain Res 1995; 32: 197-210.
17. Achim CL, Katyal S, Wiley CA, et al. Expression of HGF and cMet in the developing and adult brain. Brain Res Dev Brain Res 1997; 102: 299-303. (Pubitemid 27435951)
18. Thewke DP, Seeds NW. The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus. Brain Res 1999; 821: 356-67. (Pubitemid 29222799)
19. Sun W, Funakoshi H, Nakamura T. Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex. Brain Res Mol Brain Res 2002; 103: 36-48. (Pubitemid 34775032)
20. Korhonen L, Sjoholm U, Takei N, et al. Expression of c-Met in developing rat hippocampus: evidence for HGF as a neurotrophic factor for calbindin D-expressing neurons. Eur J Neurosci 2000; 12: 3453-3461.
21. Kadoyama K, Funakoshi H, Ohya W, Nakamura T. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Neurosci Res 2007; 59: 446-56. (Pubitemid 350007815)
22. Sun W, Funakoshi H, Nakamura T. Differential expression of hepatocyte growth factor and its receptor, c-Met in the rat retina during development. Brain Res 1999; 851: 46-53. (Pubitemid 30038128)
23. Maina F, Hilton MC, Ponzetto C, Davies AM, Klein R. Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes Dev 1997; 11: 3341-50. (Pubitemid 28023958)
24. Funakoshi H, Nakamura T. Identification of HGF-like protein as a novel neurotrophic factor for avian dorsal root ganglion sensory neurons. Biochem Biophys Res Commun 2001; 283: 606-12. (Pubitemid 32917932)
25. Sun W, Funakoshi H, Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci 2002; 22: 6537-48. (Pubitemid 35386410)
26. Kato S, Funakoshi H, Nakamura T, et al. Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation. Acta Neuropathol 2003; 106: 112-20. (Pubitemid 36869244)
27. Kitamura K, Iwanami A, Nakamura M, et al. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J Neurosci Res 2007; 85: 2332-42. (Pubitemid 47204748)
28. Di Renzo MF, Bertolotto A, Olivero M, et al. Selective expression of the Met/HGF receptor in human central nervous system microglia. Oncogene 1993; 8: 219-22. (Pubitemid 23047251)
29. Yamada T, Tsubouchi H, Daikuhara Y, et al. Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues. Brain Res 1994; 637: 308-12. (Pubitemid 24061065)
30. Gutierrez H, Dolcet X, Tolcos M, Davies A. HGF regulates the development of cortical pyramidal dendrites. Development 2004; 131: 3717-26. (Pubitemid 39199379)
31. Hamanoue M, Takemoto N, Matsumoto K, Nakamura T, Nakajima K, Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res 1996; 43: 554-64. (Pubitemid 26087390)
32. Nakano M, Takagi N, Takagi K, et al. Hepatocyte growth factor promotes the number of PSD-95 clusters in young hippocampal neurons. Exp Neurol 2007; 207: 195-202. (Pubitemid 47429654)
33. Akita H, Takagi N, Ishihara N, et al. Hepatocyte growth factor improves synaptic localization of the NMDA receptor and intracellular signaling after excitotoxic injury in cultured hippocampal neurons. Exp Neurol 2008; 210: 83-94. (Pubitemid 351258070)
34. Yan H, Rivkees SA. Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J Neurosci Res 2002; 69: 597-606. (Pubitemid 34966872)
35. Benkhoucha M, Santiago-Raber ML, Schneiter G, et al. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 2010; 107: 6424-9.
36. Campbell DB, Sutcliffe JS, Ebert PJ, et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA 2006; 103: 16834-9. (Pubitemid 44737339)
37. Campbell DB, D'Oronzio R, Garbett K, et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol 2007; 62: 243-50. (Pubitemid 47525400)
38. Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P. Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res 2008; 1: 159-68.
39. Sousa I, Clark TG, Toma C, et al. MET and autism susceptibility: family and case-control studies. Eur J Hum Genet 2009; 17: 749-58.
40. Burdick KE, DeRosse P, Kane JM, Lencz T, Malhotra AK. Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability. Am J Psychiatry 2010; 167: 436-43.
41. Cannon TD. Candidate gene studies in the GWAS era: the MET proto-oncogene, neurocognition, and schizophrenia. Am J Psychiatry 2010; 167: 369-72.
42. Schultz JM, Khan SN, Ahmed ZM, et al. Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39. Am J Hum Genet 2009; 85: 25-39.
43. Isogawa K, Akiyoshi J, Kodama K, et al. Anxiolytic effect of hepatocyte growth factor infused into rat brain. Neuropsychobiology 2005; 51: 34-38. (Pubitemid 40867988)
44. Wakatsuki M, Akiyoshi J, Ichioka S, et al. Administration of antisense DNA for hepatocyte growth factor causes an depressive and anxiogenic response in rats. Neuropeptides 2007; 41: 477-483. (Pubitemid 350101820)
45. Kanehisa M, Ishitobi Y, Ando T, et al. Serum hepatocyte growth factor levels and the effects of antidepressants in panic disorder. Neuropeptides 2010.
46. Petty MA, Wettstein JG. Elements of cerebral microvascular ischaemia. Brain Res Brain Res Rev 2001; 36: 23-34. (Pubitemid 32763127)
47. Miyazawa T, Matsumoto K, Ohmichi H, Katoh H, Yamashima T, Nakamura T. Protection of hippocampal neurons from ischemiainduced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. J Cereb Blood Flow Metab 1998; 18: 345-8. (Pubitemid 28166508)
48. Tsuzuki N, Miyazawa T, Matsumoto K, Nakamura T, Shima K, Chigasaki H. Hepatocyte growth factor reduces infarct volume after transient focal cerebral ischemia in rats. Acta Neurochir Suppl 2000; 76: 311-6.
49. Tsuzuki N, Miyazawa T, Matsumoto K, Nakamura T, Shima K. Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats. Neurol Res 2001; 23: 417-24. (Pubitemid 32552245)
50. Niimura M, Takagi N, Takagi K, Funakoshi H, Nakamura T, Takeo S. Effects of hepatocyte growth factor on phosphorylation of extracellular signal-regulated kinase and hippocampal cell death in rats with transient forebrain ischemia. Eur J Pharmacol 2006; 535: 114-24.
51. Niimura M, Takagi N, Takagi K, et al. Prevention of apoptosisinducing factor translocation is a possible mechanism for protective effects of hepatocyte growth factor against neuronal cell death in the hippocampus after transient forebrain ischemia. J Cereb Blood Flow Metab 2006; 26: 1354-65. (Pubitemid 44629884)
52. Niimura M, Takagi N, Takagi K, et al. The protective effect of hepatocyte growth factor against cell death in the hippocampus after transient forebrain ischemia is related to the improvement of apurinic/apyrimidinic endonuclease/redox factor-1 level and inhibition of NADPH oxidase activity. Neurosci Lett 2006; 407: 136-40. (Pubitemid 44397242)
53. Hayashi K, Morishita R, Nakagami H, et al. Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons. Gene Ther 2001; 8: 1167-73. (Pubitemid 32776390)
54. Ishihara N, Takagi N, Niimura M, et al. Inhibition of apoptosisinducing factor translocation is involved in protective effects of hepatocyte growth factor against excitotoxic cell death in cultured hippocampal neurons. J Neurochem 2005; 95: 1277-86. (Pubitemid 41779253)
55. Cregan SP, Dawson VL, Slack RS. Role of AIF in caspasedependent and caspase-independent cell death. Oncogene 2004; 23: 2785-96. (Pubitemid 38638842)
56. Yu SW, Wang H, Dawson TM, Dawson VL. Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol Dis 2003; 14: 303-17. (Pubitemid 37543510)
57. Shang J, Deguchi K, Yamashita T, et al. Antiapoptotic and antiautophagic effects of glial cell line-derived neurotrophic factor and hepatocyte growth factor after transient middle cerebral artery occlusion in rats. J Neurosci Res 2010: in press.
58. Date I, Takagi N, Takagi K, et al. Hepatocyte growth factor improved learning and memory dysfunction of microsphereembolized rats. J Neurosci Res 2004; 78: 442-53. (Pubitemid 39488268)
59. Shimamura M, Sato N, Oshima K, et al. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation 2004; 109: 424-31. (Pubitemid 38133914)
60. Date I, Takagi N, Takagi K, et al. Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels. Neurosci Lett 2006; 407: 141-5. (Pubitemid 44397240)
61. Takeo S, Takagi N, Takagi K, et al. Hepatocyte growth factor suppresses ischemic cerebral edema in rats with microsphere embolism. Neurosci Lett 2008; 448: 125-129.
62. Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 1998; 27: 1-39. (Pubitemid 28300281)
63. Date I, Takagi N, Takagi K, et al. Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunction. Biochem Biophys Res Commun 2004; 319: 1152-8. (Pubitemid 38759532)
64. Shimamura M, Sato N, Waguri S, et al. Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction. Hypertension 2006; 47: 742-751. (Pubitemid 43740247)
65. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001; 2: 806-19. (Pubitemid 33674062)
66. Cheah BC, Vucic S, Krishnan AV, Kiernan MC. Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem; 17: 1942-199.
67. Siciliano G, Carlesi C, Pasquali L, et al. Clinical Trials for Neuroprotection in ALS. CNS Neurol Disord Drug Targets 2010.
68. Ebens A, Brose K, Leonardo ED, et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 1996; 17: 1157-72. (Pubitemid 27021101)
69. Yamamoto Y, Livet J, Pollock RA, et al. Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation of embryonic motoneurons. Development 1997; 124: 2903-2913. (Pubitemid 27370906)
70. Novak KD, Prevette D, Wang S, Gould TW, Oppenheim RW. Hepatocyte growth factor/scatter factor is a neurotrophic survival factor for lumbar but not for other somatic motoneurons in the chick embryo. J Neurosci 2000; 20: 326-37. (Pubitemid 30220520)
71. Okura Y, Arimoto H, Tanuma N, et al. Analysis of neurotrophic effects of hepatocyte growth factor in the adult hypoglossal nerve axotomy model. Eur J Neurosci 1999; 11: 4139-44. (Pubitemid 29537593)
72. Hayashi Y, Kawazoe Y, Sakamoto T, et al. Adenoviral gene transfer of hepatocyte growth factor prevents death of injured adult motoneurons after peripheral nerve avulsion. Brain Res 2006; 1111: 187-95. (Pubitemid 44331181)
73. Koyama J, Yokouchi K, Fukushima N, Kawagishi K, Higashiyama F, Moriizumi T. Neurotrophic effect of hepatocyte growth factor on neonatal facial motor neurons. Neurol Res 2003; 25: 701-7. (Pubitemid 37266692)
74. Ishigaki A, Aoki M, Nagai M, et al. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model. J Neuropathol Exp Neurol 2007; 66: 1037-44. (Pubitemid 350060371)
75. Gandino L, Longati P, Medico E, Prat M, Comoglio PM. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J Biol Chem 1994; 269: 1815-20. (Pubitemid 24035378)
76. Hashigasako A, Machide M, Nakamura T, Matsumoto K. Bidirectional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J Biol Chem 2004; 279: 26445-52. (Pubitemid 38798797)
77. Kadoyama K, Funakoshi H, Ohya-Shimada W, Nakamura T, Matsumoto K, Matsuyama S. Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS. Neurosci Res 2009; 65: 194-200.
78. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8: 101-12. (Pubitemid 46432529)
79. Citron M. Alzheimer's disease: strategies for disease modification. Nat Rev Drug Discov 2010; 9: 387-98.
80. Takeuchi D, Sato N, Shimamura M, et al. Alleviation of Abetainduced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model. Gene Ther 2008; 15: 561-71.
81. Figurov A, Pozzo-Miller LD, Olafsson P, Wang T, Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 1996; 381: 706-9. (Pubitemid 26196571)
82. Tyndall SJ, Walikonis RS. The receptor tyrosine kinase Met and its ligand hepatocyte growth factor are clustered at excitatory synapses and can enhance clustering of synaptic proteins. Cell Cycle 2006; 5: 1560-8. (Pubitemid 44091977)
83. Akimoto M, Baba A, Ikeda-Matsuo Y, et al. Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus. Neuroscience 2004; 128: 155-62. (Pubitemid 39140688)
84. Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 2004; 5: 771-781. (Pubitemid 39336214)
85. Shastry BS. Parkinson disease: etiology, pathogenesis and future of gene therapy. Neurosci Res 2001; 41: 5-12. (Pubitemid 32776631)
86. Koike H, Ishida A, Shimamura M, et al. Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease. Gene Ther 2006; 13: 1639-44. (Pubitemid 44774208)
87. Sauer H, Oertel WH. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6- hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994; 59: 401-15. (Pubitemid 24098798)
88. Hagg T, Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma 2006; 23: 264-80. (Pubitemid 43726309)
89. Lalive PH, Paglinawan R, Biollaz G, et al. TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. Eur J Immunol 2005; 35: 727-37. (Pubitemid 40425528)
90. Tada T, Zhan H, Tanaka Y, Hongo K, Matsumoto K, Nakamura T. Intraventricular administration of hepatocyte growth factor treats mouse communicating hydrocephalus induced by transforming growth factor beta1. Neurobiol Dis 2006; 21: 576-586. (Pubitemid 43277541)
91. Bae MH, Bissonette GB, Mars WM, et al. Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility. Exp Neurol 2010; 221: 129-35.
92. Machida S, Tanaka M, Ishii T, Ohtaka K, Takahashi T, Tazawa Y. Neuroprotective effect of hepatocyte growth factor against photoreceptor degeneration in rats. Invest Ophthalmol Vis Sci 2004; 45: 4174-82. (Pubitemid 39411177)
93. Oshima K, Shimamura M, Mizuno S, et al. Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats. FASEB J 2004; 18: 212-4.
94. Tsuchihara T, Ogata S, Nemoto K, et al. Nonviral retrograde gene transfer of human hepatocyte growth factor improves neuropathic pain-related phenomena in rats. Mol Ther 2009; 17: 42-50.
95. Funakoshi H, Kadoyama K, Ohya W, Nakamura T. Neuroprotective role of HGF and its molecular mecahnisms. Clinical Neuroscience 2007; 25: 620 (in Japanese).
96. Lim CS, Walikonis RS. Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway. Cell Signal 2008; 20: 825-35.
97. He F, Wu LX, Shu KX, et al. HGF protects cultured cortical neurons against hypoxia/reoxygenation induced cell injury via ERK1/2 and PI-3K/Akt pathways. Colloids Surf B Biointerfaces 2008; 61: 290-7.
98. Zhang L, Himi T, Morita I, Murota S. Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway. J Neurosci Res 2000; 59: 489-96. (Pubitemid 30090575)
99. Hossain MA, Russell JC, Gomez R, Laterra J. Neuroprotection by scatter factor/hepatocyte growth factor and FGF-1 in cerebellar granule neurons is phosphatidylinositol 3-kinase/akt-dependent and MAPK/CREB-independent. J Neurochem 2002; 81: 365-78. (Pubitemid 34809362)
100. Powell EM, Muhlfriedel S, Bolz J, Levitt P. Differential regulation of thalamic and cortical axonal growth by hepatocyte growth factor/scatter factor. Dev Neurosci 2003; 25: 197-206. (Pubitemid 37100214)
101. Maina F, Hilton MC, Andres R, Wyatt S, Klein R, Davies AM. Multiple roles for hepatocyte growth factor in sympathetic neuron development. Neuron 1998; 20: 835-46. (Pubitemid 28247390)
102. Thompson J, Dolcet X, Hilton M, Tolcos M, Davies AM. HGF promotes survival and growth of maturing sympathetic neurons by PI-3 kinase- and MAP kinase-dependent mechanisms. Mol Cell Neurosci 2004; 27: 441-52. (Pubitemid 39539998)
103. Yang XM, Toma JG, Bamji SX, et al. Autocrine hepatocyte growth factor provides a local mechanism for promoting axonal growth. J Neurosci 1998; 18: 8369-81. (Pubitemid 28465012)
104. Davey F, Hilton M, Davies AM. Cooperation between HGF and CNTF in promoting the survival and growth of sensory and parasympathetic neurons. Mol Cell Neurosci 2000; 15: 79-87. (Pubitemid 30090382)
105. Garzotto D, Giacobini P, Crepaldi T, Fasolo A, De Marchis S. Hepatocyte growth factor regulates migration of olfactory interneuron precursors in the rostral migratory stream through Met-Grb2 coupling. J Neurosci 2008; 28: 5901-09.
106. Machide M, Kamitori K, Kohsaka S. Hepatocyte growth factorinduced differential activation of phospholipase cgamma 1 and phosphatidylinositol 3-kinase is regulated by tyrosine phosphatase SHP-1 in astrocytes. J Biol Chem 2000; 275: 31392-8.
107. Krasnoselsky A, Massay MJ, DeFrances MC, Michalopoulos G, Zarnegar R, Ratner N. Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas. J Neurosci 1994; 14: 7284-90. (Pubitemid 24379740)
108. Yan H, Nie X, Kocsis JD. Hepatocyte growth factor is a mitogen for olfactory ensheathing cells. J Neurosci Res 2001; 66: 698-704. (Pubitemid 33032339)
109. Nicoleau C, Benzakour O, Agasse F, et al. Endogenous hepatocyte growth factor is a niche signal for subventricular zone neural stem cell amplification and self-renewal. Stem Cells 2009; 27: 408-19.
110. Caton A, Hacker A, Naeem A, et al. The branchial arches and HGF are growth-promoting and chemoattractant for cranial motor axons. Development 2000; 127: 1751-66. (Pubitemid 30234931)
111. Elsen GE, Choi LY, Prince VE, Ho RK. The autism susceptibility gene met regulates zebrafish cerebellar development and facial motor neuron migration. Dev Biol 2009; 335: 78-92.
112. Powell EM, Campbell DB, Stanwood GD, Davis C, Noebels JL, Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci 2003; 23: 622-31. (Pubitemid 36139561)
113. Powell EM, Mars WM, Levitt P. Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron 2001; 30: 79-89. (Pubitemid 32441678)
114. Ieraci A, Forni PE, Ponzetto C. Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development. Proc Natl Acad Sci USA 2002; 99: 15200-05. (Pubitemid 35334633)
115. Giacobini P, Messina A, Wray S, et al. Hepatocyte growth factor acts as a motogen and guidance signal for gonadotropin hormonereleasing hormone-1 neuronal migration. J Neurosci 2007; 27: 431-45. (Pubitemid 46106017)
116. Sugihara G, Hashimoto K, Iwata Y, et al. Decreased serum levels of hepatocyte growth factor in male adults with high-functioning autism. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 412-5. (Pubitemid 46209427)
117. Yoshimura S, Morishita R, Hayashi K, et al. Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model. Hypertension 2002; 39: 1028-34. (Pubitemid 34547804)
118. Zhao MZ, Nonoguchi N, Ikeda N, et al. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J Cereb Blood Flow Metab 2006; 26: 1176-88. (Pubitemid 44268180)
119. Ohtaka K, Machida S, Ohzeki T, et al. Protective effect of hepatocyte growth factor against degeneration of the retinal pigment epithelium and photoreceptor in sodium iodate-injected rats. Curr Eye Res 2006; 31: 347-55.
120. Inaoka T, Nakagawa T, Kikkawa YS, et al. Local application of hepatocyte growth factor using gelatin hydrogels attenuates noiseinduced hearing loss in guinea pigs. Acta Otolaryngol 2009; 129: 453-7.
121. Kato N, Nemoto K, Nakanishi K, et al. Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve. Neurosci Res 2005; 52: 299-310. (Pubitemid 40917208)
122. Kato N, Nemoto K, Nakanishi K, et al. Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats. Diabetes 2005; 54: 846-54. (Pubitemid 40322090)
123. Hobara N, Yoshida N, Goda M, et al. Neurotrophic effect of hepatic growth factor (HGF) on reinnervation of perivascular calcitonin gene-related peptide (CGRP)-containing nerves following phenol-induced nerve injury in the rat mesenteric artery. J Pharmacol Sci 2008; 108: 495-504.
124. Li Z, Peng J, Wang G, et al. Effects of local release of hepatocyte growth factor on peripheral nerve regeneration in acellular nerve grafts. Exp Neurol 2008.